The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia
Open accessAbstract
Postoperative cognitive dysfunction, confusion, and delirium are common after general anesthesia in the elderly, with symptoms persisting for months or years in some patients. Even middle-aged patients are likely to have postoperative cognitive dysfunction for months after surgery, and Alzheimer's disease (AD) patients appear to be particularly at risk of deterioration after anesthesia. Several investigators have thus examined whether general anesthesia is associated with AD, with some studies suggesting that exposure to anesthetics may increase the risk of AD. However, little is known on the biochemical consequences of anesthesia on pathogenic pathways in vivo . Here, we investigated the effect of anesthesia on tau phosphorylation and amyloid precursor protein (APP) metabolism in mouse brain. We found that, regardless of the anesthetic used, anesthesia induced rapid and massive hyperphosphorylation of tau, rapid and prolonged hypothermia, inhibition of Ser/Thr PP2A (protein phosphatase 2A), but no changes in APP metabolism or Aβ (β-amyloid peptide) accumulation. Reestablishing normothermia during anesthesia completely rescued tau phosphorylation to normal levels. Our results indicate that changes in tau phosphorylation were not a result of anesthesia per se, but a consequence of anesthesia-induced hypothermia, which led to inhibition of phosphatase activity and subsequent hyperphosphorylation of tau. These findings call for careful monitoring of core temperature during anesthesia in laboratory animals to avoid artifactual elevation of protein phosphorylation. Furthermore, a thorough examination of the effect of anesthesia-induced hypothermia on the risk and progression of AD is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
THE STRUCTURE AND REGULATION OF PROTEIN PHOSPHATASES
Cohen, P. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.002321 · Cited by 2,524
Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study
Moller, J., Cluitmans, P., Rasmussen, L., Houx, P., Rasmussen, H., Canet, J., Rabbitt, P., Jolles, J., Larsen, K., Hanning, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07382-0 · Cited by 2,422
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Alonso, A. D. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 827
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Braak, F., Braak, H., & Mandelkow, E. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 772
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 1×
“Membrane blocking and antibody incubations were performed as described previously (Noble et al., 2005), with appropriate primary and secondary antibody dilutions.”
MethodSelf-citationMonoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Matsuo, E. S., Shin, R.-W., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., & Lee, V. M. Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 576
Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527 · cited 1×
“In AD, decreased PP2A expression (Vogelsberg-Ragaglia et al., 2001) along with upregulation of its inhibitors (Tanimukai et al., 2005) result in overall inhibition of its activity (Gong et al., 1993, 1995), which might be an important factor in the evolution of the pathology (Tian and Wang, 2002).”
BackgroundMonoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488 · cited 1×
“…antibodies (specificity given in parentheses) were a generous gift from Dr. Peter Davies (Albert Einstein University, New York, NY): TG-3, phospho-Ser231 and conformation specific (Jicha et al., 1997); MC-6, phospho-Ser235 (Jicha et al., 1997); and PHF-1, phospho-Ser396/404 (Otvos et al., 1994).”
BackgroundAcute Confusional States in Elderly Patients Treated for Femoral Neck Fracture
Gustafson, Y., Berggren, D., Brännström, B., Bucht, G., Norberg, A., Hansson, L.-I., & Winblad, B. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb04023.x · Cited by 474
ADVERSE CEREBRAL EFFECTS OF ANÆSTHESIA ON OLD PEOPLE
Bedford, P. D. (1955) · The Lancet · doi:10.1016/s0140-6736(55)92689-1 · Cited by 472
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain
Gong, C., Shaikh, S., Wang, J., Zaidi, T., Grundke‐Iqbal, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020732.x · Cited by 438
Gong, C.-X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., & Iqbal, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5535 · Cited by 405
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease
Zhu, X., Lee, H.-G., Raina, A. K., Perry, G., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067426 · Cited by 391
Postoperative Cognitive Dysfunction in Middle-aged Patients
Johnson, T., Monk, T., Rasmussen, L. S., Abildstrom, H., Houx, P., Korttila, K., Kuipers, H. M., Hanning, C. D., Siersma, V. D., Kristensen, D., et al. (2002) · Anesthesiology · doi:10.1097/00000542-200206000-00014 · Cited by 378
Inhaled Anesthetic Enhancement of Amyloid-β Oligomerization and Cytotoxicity
Eckenhoff, R. G., Johansson, J. S., Wei, H., Carnini, A., Kang, B., Wei, W., Pidikiti, R., Keller, J. M., & Eckenhoff, M. F. (2004) · Anesthesiology · doi:10.1097/00000542-200409000-00019 · Cited by 376
Amaducci, L. A., Fratiglioni, L., Rocca, W. A., Fieschi, C., Livrea, P., Pedone, D., Bracco, L., Lippi, A., Gandolfo, C., Bino, G., et al. (1986) · Neurology · doi:10.1212/wnl.36.7.922 · Cited by 365
Reynolds, C. H., Betts, J. C., Blackstock, W. P., Nebreda, A. R., & Anderton, B. H. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741587.x · Cited by 362
The Common Inhalation Anesthetic Isoflurane Induces Apoptosis and Increases Amyloid β Protein Levels
Xie, Z., Dong, Y., Maeda, U., Alfille, P., Culley, D. J., Crosby, G., & Tanzi, R. E. (2006) · Anesthesiology · doi:10.1097/00000542-200605000-00015 · Cited by 304
Tau phosphorylation and aggregation in Alzheimer's disease pathology
Avila, J. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.067 · Cited by 282
PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus
Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7630 · Cited by 281 · cited 1×
“In AD, decreased PP2A expression (Vogelsberg-Ragaglia et al., 2001) along with upregulation of its inhibitors (Tanimukai et al., 2005) result in overall inhibition of its activity (Gong et al., 1993, 1995), which might be an important factor in the evolution of the pathology (Tian and Wang, 2002).”
BackgroundGoedert, M., Cohen, E. S., Jakes, R., & Cohen, P. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81418-l · Cited by 272
Jicha, G. A., Lane, E., Vincent, I., Otvos, L., Hoffmann, R., & Davies, P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052087.x · Cited by 264
Planel, E., Miyasaka, T., Launey, T., Chui, D.-H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., & Takashima, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5561-03.2004 · Cited by 261
Self-citationA CASE-CONTROL STUDY OF DEMENTIA OF THE ALZHEIMER TYPE
FRENCH, L. R., SCHUMAN, L. M., MORTIMER, J. A., HUTTON, J. T., BOATMAN, R. A., & CHRISTIANS, B. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114013 · Cited by 244
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer’s disease
Tanimukai, H., Grundke-Iqbal, I., & Iqbal, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62486-8 · Cited by 220
Postoperative delirium in the elderly
O'KEEFFE, S. T., & CHONCHUBHAIR, Á. N. (1994) · British Journal of Anaesthesia · doi:10.1093/bja/73.5.673 · Cited by 207
Szendrei, G. I., Lee, V. M. ‐., & Otvos, L. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340212 · Cited by 200
Planel, E., Yasutake, K., Fujita, S. C., & Ishiguro, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102780200 · Cited by 197
Self-citationMaccioni, R. B., Otth, C., Concha, I. I., & Muñoz, J. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02024.x · Cited by 191
Bennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184 · cited 1×
“In vivo and slice culture studies have demonstrated that PP2A is likely to be the main regulator of tau phosphorylation physiologically, whereas PP1 and PP2B are minimally involved (Bennecib et al., 2000; Gong et al., 2000; Planel et al., 2001, 2004).”
BackgroundBreteler, M. M. B., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s36 · Cited by 181
Wang, J., Grundke, I., & Iqbal, K. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00316-k · Cited by 175
Role of Serine/Threonine Protein Phosphatase in Alzheimer’s Disease
Tian, Q., & Wang, J. (2002) · Neurosignals · doi:10.1159/000067425 · Cited by 172
Burns, M., Gaynor, K., Olm, V., Mercken, M., LaFrancois, J., Wang, L., Mathews, P. M., Noble, W., Matsuoka, Y., & Duff, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05645.2003 · Cited by 172
Self-citationClinical risk factors for Alzheimer's disease: A population‐based case‐control study
Kokmen, E., Beard, C. M., Chandra, V., Offord, K. P., Schoenberg, B. S., & Ballard, D. J. (1991) · Neurology · doi:10.1212/wnl.41.9.1393 · Cited by 170
Litersky, J. M., Johnson, G. V. W., Jakes, R., Goedert, M., Michael, L. E. E., & Seubert, P. A. (1996) · Biochemical Journal · doi:10.1042/bj3160655 · Cited by 165
Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly
Ancelin, M.-L., De Roquefeuil, G., Ledésert, B., Bonnel, F., Cheminal, J.-C., & Ritchie, K. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.178.4.360 · Cited by 160
Alzheimer's disease and post-operative cognitive dysfunction
Xie, Z., & Tanzi, R. E. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.01.014 · Cited by 159
Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro
Ksiȩżak-Reding, H., Pyo, H. K., Feinstein, B., & Pasinetti, G. M. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.09.001 · Cited by 151
Truncation of CDK5 Activator p35 Induces Intensive Phosphorylation of Ser202/Thr205 of Human Tau
Hashiguchi, M., Saito, T., Hisanaga, S., & Hashiguchi, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207426200 · Cited by 149
Calpain‐mediated degradation of p35 to p25 in postmortem human and rat brains
Taniguchi, S., Fujita, Y., Hayashi, S., Kakita, A., Takahashi, H., Murayama, S., Saido, T. C., Hisanaga, S., Iwatsubo, T., & Hasegawa, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02431-5 · Cited by 148
Early and Midlife Exposure to Anesthesia and Age of Onset of Alzheimer's Disease
Bohnen, N. I., Warner, M. A., Kokmen, E., & Kurland, L. T. (1994) · International Journal of Neuroscience · doi:10.3109/00207459408986029 · Cited by 126
Paired helical filament tau in Alzheimer's disease. The kinase connection.
Trojanowski, J. Q., & Lee, V. M. ‐. (1994) · PubMed · Cited by 124
Hypothermia in mice tested in Morris water maze
Iivonen, H., Nurminen, L., Harri, M. N. E., Tanila, H., & Puoliväli, J. T. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00369-8 · Cited by 120
Huitrón‐Reséndiz, S., Sánchez-Alavez, M., Gallegos, R. A., Berg, G. I., Crawford, E. F., Giacchino, J. L., Games, D., Henriksen, S. J., & Criado, J. R. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03373-x · Cited by 119
Su, J. H., Cummings, B. J., & Cotman, C. W. (1994) · Neuroreport · doi:10.1097/00001756-199411000-00037 · Cited by 110
Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein
Mathews, P. M., Jiang, Y., Schmidt, S. D., Grbovic, O. M., Mercken, M. H., & Nixon, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205208200 · Cited by 105
Bussière, T., Hof, P. R., Vanbesien-Mailliot, C., Brown, C., Caillet‐Boudin, M., Perl, D. P., Buée, L., & Delacourte, A. (1999) · Acta Neuropathologica · doi:10.1007/s004010050978 · Cited by 102
Stress‐induced hyperphosphorylation of tau in the mouse brain
Okawa, Y., Ishiguro, K., & Fujita, S. C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03883-8 · Cited by 98
Role of GSK‐3β in Alzheimer's disease pathology
Planel, E., Sun, X., & Takashima, A. (2002) · Drug Development Research · doi:10.1002/ddr.10100 · Cited by 96
Self-citationA population-based study on the association between dementia and hip fractures in 85-year olds
Johansson, C., & Skoog, I. G. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03339676 · Cited by 84
Sironi, J., Yen, S.-H. C., Gondal, J. A., Wu, Q., Grundke, I., & Iqbal, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01185-5 · Cited by 83
ELISA Method for Measurement of Amyloid-β Levels
Schmidt, S. D., Nixon, R. A., & Mathews, P. M. (2005) · Humana Press eBooks · doi:10.1385/1-59259-874-9:279 · Cited by 80
Sergeant, N., David, J., Champain, D., Ghestem, A., Wattez, A., & Delacourte, A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00901.x · Cited by 68
Li, X., Friedman, A. B., Roh, M., & Jope, R. S. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02898.x · Cited by 64
Assay and purification of protein (serine/threonine) phosphatases
MacKintosh, C. (1993) · Oxford University Press eBooks · doi:10.1093/oso/9780199633067.003.0009 · Cited by 52
Maurage, C.-A., Sergeant, N., Ruchoux, M.-M., Hauw, J.-J., & Delacourte, A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0608-7 · Cited by 51 · cited 2×
“, 1999), and pS199, which is considered an early marker of tau pathology (Maurage et al., 2003).”
BackgroundImpact of Anesthesia on the Cognitive Functioning of the Elderly
Ritchie, K. A., Polge, C., de Roquefeuil, G., Djakovic, M., & Ledésert, B. (1997) · International Psychogeriatrics · doi:10.1017/s1041610297004468 · Cited by 51
Duff, K., & Planel, E. (2005) · Nature Medicine · doi:10.1038/nm0805-826 · Cited by 46
Self-citationThermal management of the patient: where does the patient lose and/or gain temperature?
Taguchi, A., & Kurz, A. M. (2005) · Current Opinion in Anaesthesiology · doi:10.1097/01.aco.0000191890.36691.cc · Cited by 36
Effect of General Anesthetics on Amyloid Precursor Protein and mRNA Levels in the Rat Brain
Palotás, M., Palotás, A., Bjelik, A., Pákáski, M., Hugyecz, M., Janka, Z., & Kalman, J. L. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6786-7 · Cited by 29
Body temperature as a risk factor for Alzheimer’s disease
Holtzman, A. H., & Simon, E. W. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1085 · Cited by 27
Ávila, J., & Díaz‐Nido, J. (2004) · Nature Medicine · doi:10.1038/nm0504-460 · Cited by 26
Alzheimer’s disease and anaesthesia
Bone, I., & Rosen, M. (2000) · Anaesthesia · doi:10.1046/j.1365-2044.2000.01479-5.x · Cited by 15
Cited by
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Tau in Alzheimer Disease and Related Tauopathies
Iqbal, K., Liu, F., Gong, C.-X., & Grundke-Iqbal, I. (2010) · Current Alzheimer Research · doi:10.2174/156720510793611592 · Cited by 1,127
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
Mandelkow, E.-M., & Mandelkow, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006247 · Cited by 847
BIS-guided Anesthesia Decreases Postoperative Delirium and Cognitive Decline
Chan, M. T. V., Cheng, B. C. P., Lee, T. M. C., & Gin, T. (2013) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0b013e3182712fba · Cited by 713
Metadata
- Authors
- Planel, E., Richter, K. E. G., Nolan, C. E., Finley, J. E., Liu, L., Wen, Y., Krishnamurthy, P., Herman, M., Wang, L., Schachter, J. B., Nelson, R. B., Lau, L.-F., & Duff, K. E.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-03-21
- Volume
- 27
- Issue
- 12
- Pages
- 3090-3097
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2077859404
- Cited by
- 386
- References
- 70
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.